tradingkey.logo

Enovis Corp

ENOV
31.240USD
+0.550+1.79%
收盤 10/31, 16:00美東報價延遲15分鐘
1.79B總市值
虧損本益比TTM

Enovis Corp

31.240
+0.550+1.79%

關於 Enovis Corp 公司

Enovis Corporation 是一家醫療技術公司。該公司專注於通過製造和分銷醫療設備來開發臨牀差異化解決方案,其產品系列用於重建手術、康復、疼痛管理和物理治療。該公司通過兩個部門運營:預防與恢復和重建。預防與恢復部門開發、製造和分銷剛性支撐產品、矯形軟質產品、血管系統和壓縮服裝以及冷熱療法產品,並在臨牀康復和運動醫學市場提供恢復科學產品,例如用於疼痛管理的骨骼生長刺激器和電刺激器。重建部門開發、製造和銷售各種膝蓋、臀部、肩膀、肘部、腳踝和手指植入物產品和手術生產力工具。該公司還提供 Novastep,一種微創手術 (MIS) 足部和踝關節解決方案。

Enovis Corp簡介

公司代碼ENOV
公司名稱Enovis Corp
上市日期May 08, 2008
CEOMr. Damien Mcdonald
員工數量7367
證券類型Ordinary Share
年結日May 08
公司地址2711 Centerville Road
城市WILMINGTON
上市交易所NYSE Consolidated
國家United States of America
郵編19808
電話13022529160
網址https://www.enovis.com/
公司代碼ENOV
上市日期May 08, 2008
CEOMr. Damien Mcdonald

Enovis Corp公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
114.51K
+9.57%
Mr. Damien Mcdonald
Mr. Damien Mcdonald
Chief Executive Officer, Director
Chief Executive Officer, Director
102.75K
+6.71%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
35.79K
-0.90%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
28.26K
+30.46%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
20.37K
+47.89%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
15.27K
+76.12%
Ms. Barbara W. Bodem
Ms. Barbara W. Bodem
Independent Director
Independent Director
10.52K
+168.36%
Dr. Christine Ortiz, Ph.D.
Dr. Christine Ortiz, Ph.D.
Independent Director
Independent Director
10.52K
+168.36%
Mr. Philip A. Okala
Mr. Philip A. Okala
Independent Director
Independent Director
--
--
Ms. Angela S. Lalor
Ms. Angela S. Lalor
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
114.51K
+9.57%
Mr. Damien Mcdonald
Mr. Damien Mcdonald
Chief Executive Officer, Director
Chief Executive Officer, Director
102.75K
+6.71%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
35.79K
-0.90%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
28.26K
+30.46%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
20.37K
+47.89%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
15.27K
+76.12%

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
International Reconstructive
144.48M
25.59%
U.S. Reconstructive
129.49M
22.94%
U.S. Bracing & Support
120.85M
21.41%
International P&R
98.90M
17.52%
U.S. Other P&R
70.82M
12.55%
暫無數據
業務
地區
業務USD
名稱
營收
佔比
International Reconstructive
144.48M
25.59%
U.S. Reconstructive
129.49M
22.94%
U.S. Bracing & Support
120.85M
21.41%
International P&R
98.90M
17.52%
U.S. Other P&R
70.82M
12.55%

股東統計

更新時間: 10月22日 週三
更新時間: 10月22日 週三
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
14.03%
The Vanguard Group, Inc.
11.14%
American Century Investment Management, Inc.
8.29%
Dimensional Fund Advisors, L.P.
5.11%
Davenport Asset Management
4.91%
其他
56.53%
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
14.03%
The Vanguard Group, Inc.
11.14%
American Century Investment Management, Inc.
8.29%
Dimensional Fund Advisors, L.P.
5.11%
Davenport Asset Management
4.91%
其他
56.53%
股東類型
持股股東
佔比
Investment Advisor
60.74%
Investment Advisor/Hedge Fund
37.03%
Hedge Fund
14.15%
Research Firm
5.59%
Individual Investor
1.59%
Bank and Trust
1.27%
Pension Fund
1.09%
Venture Capital
0.13%
Sovereign Wealth Fund
0.05%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
636
68.64M
120.08%
-5.33M
2025Q2
641
62.33M
109.11%
-9.18M
2025Q1
646
68.39M
119.73%
-3.70M
2024Q4
637
64.20M
113.02%
-5.55M
2024Q3
613
62.53M
111.92%
-6.94M
2024Q2
617
64.91M
118.38%
-5.04M
2024Q1
651
62.70M
114.40%
-9.13M
2023Q4
661
61.64M
112.95%
-6.99M
2023Q3
653
60.52M
110.96%
-10.76M
2023Q2
641
59.95M
109.96%
-8.07M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
8.02M
14.03%
+1.50M
+22.95%
Jun 30, 2025
The Vanguard Group, Inc.
6.37M
11.14%
+288.04K
+4.74%
Jun 30, 2025
American Century Investment Management, Inc.
4.74M
8.29%
+1.21M
+34.39%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
2.92M
5.11%
-7.00K
-0.24%
Jun 30, 2025
Davenport Asset Management
2.76M
4.82%
-86.99K
-3.06%
Jul 31, 2025
Dorsey Asset Management LLC
2.55M
4.47%
+2.55M
--
Jun 30, 2025
State Street Investment Management (US)
2.49M
4.35%
+592.50K
+31.27%
Jun 30, 2025
Royce Investment Partners
2.42M
4.23%
-71.88K
-2.89%
Jun 30, 2025
Hood River Capital Management LLC
1.74M
3.04%
+292.95K
+20.31%
Jun 30, 2025
River Road Asset Management, LLC
1.44M
2.52%
+48.04K
+3.45%
Jun 30, 2025
查看更多

持股ETF

更新時間: 10月6日 週一
更新時間: 10月6日 週一
機構名稱
佔比
SPDR S&P Health Care Equipment ETF
1.67%
Invesco S&P SmallCap Health Care ETF
1.19%
Invesco S&P SmallCap 600 Pure Value ETF
0.43%
VictoryShares US Small Mid Cap Value Momentum ETF
0.29%
SPDR S&P 600 Small Cap Value ETF
0.25%
iShares S&P Small-Cap 600 Value ETF
0.25%
iShares U.S. Medical Devices ETF
0.2%
Humankind US Stock ETF
0.2%
Avantis US Small Cap Equity ETF
0.2%
SPDR S&P SmallCap 600 ESG ETF
0.17%
查看更多
SPDR S&P Health Care Equipment ETF
佔比1.67%
Invesco S&P SmallCap Health Care ETF
佔比1.19%
Invesco S&P SmallCap 600 Pure Value ETF
佔比0.43%
VictoryShares US Small Mid Cap Value Momentum ETF
佔比0.29%
SPDR S&P 600 Small Cap Value ETF
佔比0.25%
iShares S&P Small-Cap 600 Value ETF
佔比0.25%
iShares U.S. Medical Devices ETF
佔比0.2%
Humankind US Stock ETF
佔比0.2%
Avantis US Small Cap Equity ETF
佔比0.2%
SPDR S&P SmallCap 600 ESG ETF
佔比0.17%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
公告日期
類型
比率
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
KeyAI